Deltex has released a pre-close trading update for the year to December 2018 highlighting improved profitability through Q4 2018. The Group indicates that FY18 revenue is slightly below expectations with operating losses (pre-exceptionals) broadly inline with market expectations. In our view, the new strategy is driving a path to better overall profitability which should benefit the shares over time.
25 Jan 2019
New strategy providing solid base
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
New strategy providing solid base
Deltex Medical Group plc (DEMG:LON) | 0.1 0 0.0% | Mkt Cap: 2.46m
- Published:
25 Jan 2019 -
Author:
Andrew Simms -
Pages:
2
Deltex has released a pre-close trading update for the year to December 2018 highlighting improved profitability through Q4 2018. The Group indicates that FY18 revenue is slightly below expectations with operating losses (pre-exceptionals) broadly inline with market expectations. In our view, the new strategy is driving a path to better overall profitability which should benefit the shares over time.